Moody National Bank Trust Division’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Moody National Bank Trust Division’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-319	Closed	-$8K	–	1161
2019 Q1	$8K	Hold	319	–	–	﹤0.01%	699
2018 Q4	$6K	Buy	+319	New	+$6.25K	﹤0.01%	735
2017 Q3	–	Sell	-18,265	Closed	-$216K	–	278
2017 Q2	$216K	Hold	18,265	–	–	0.01%	256
2017 Q1	$270K	Hold	18,265	–	–	0.01%	241
2016 Q4	$296K	Hold	18,265	–	–	0.01%	224
2016 Q3	$331K	Hold	18,265	–	–	0.02%	216
2016 Q2	$301K	Hold	18,265	–	–	0.02%	220
2016 Q1	$302K	Hold	18,265	–	–	0.02%	213
2015 Q4	$396K	Buy	+18,265	New	+$356K	0.03%	173

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Moody National Bank Trust Division's HZNP Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2019, closing a stake of 319 shares — an estimated $8K sold.

Moody National Bank Trust Division first reported a position in HZNP in Q4 2015 and held it in 9 quarters. The position peaked at $396K in Q4 2015. 272 funds tracked by Wall St. Rank hold HZNP as of Q2 2019.

Moody National Bank Trust Division reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2019 after selling out during the quarter.
Moody National Bank Trust Division sold 319 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2019, an estimated $8K.
Moody National Bank Trust Division first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and held it in 9 quarters.
Moody National Bank Trust Division's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $396K in Q4 2015.
272 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.